Theravance BioPharma

TBPH

16.8600.06% ( +0.010 )

Trading: Jul 30, 13:20:41 (EDT)

Q1 FY2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Preview: Theravance BioPharma(TBPH) predict that the Revenue is 17.7 M (+15.02%), Beat estimate;the EBIT is -9.483 M (+34.3%), Miss estimate;the EPS is -0.1 (+62.96%), Miss estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueExceed expectations

0.02B15.02%

0.02B13.40%

+0.00B1.62%

EBITMiss expectations

-0.01B34.30%

-0.01B55.89%

-0.00B21.59%

EPSMiss expectations

-0.162.96%

0.028110.37%

-0.128047.41%

Revenue

ActualEstimateUnit: USD

EBIT

ActualEstimateUnit: USD

Net income

ActualEstimateUnit: USD

EPS

ActualEstimateUnit: USD